X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.euroapi.com/en/fighting-tuberculosis-EUROAPI-rifampicin-meets-new-requirements-for-nitrosamine-impurity-standards
https://www.contractpharma.com/contents/view_experts-opinion/2023-06-23/n-nitrosamine-risk-assessments-for-oral-dosage-forms/?widget=listSection
https://recalls-rappels.canada.ca/en/alert-recall/amitriptyline-antidepressant-drugs-recalled-because-nitrosamine-impurity
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-set-remove-cancer-causing-chemical-top-diabetes-drugs-bloomberg-news-2023-01-17/
https://endpts.com/deciphera-revives-hopes-for-qinlock-with-subgroup-analysis-plots-new-phiii-but-market-reaction-is-muted/
https://endpts.com/generic-drug-industry-pushes-fda-to-address-nitrosamine-impurities-in-a-new-way/
https://www.raps.org/news-and-articles/news-articles/2022/10/prompted-by-recent-recalls-regulators-scramble-to
https://www.forbes.com/sites/brucelee/2022/10/30/fda-heres-yet-another-blood-pressure-medication-recall-for-cancer-concerns/?sh=6c558b03250d
https://endpts.com/aurobindo-pharmas-us-branch-issues-a-recall-of-two-generic-medicines/
https://www.api.polpharma.com/news/safe-approach-in-delivering-nitrosamine-free-api-products/
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sandoz-inc-issues-nationwide-recall-13-lots-orphenadrine-citrate-100-mg-extended-release-tablets-due
https://recalls-rappels.canada.ca/en/alert-recall/pfizer-recalls-accuretic-blood-pressure-tablets-due-nitrosamine-impurity
https://www.fiercepharma.com/pharma/pfizer-following-last-years-chantix-recall-pulls-blood-pressure-med-canada-carcinogen-fears
https://recalls-rappels.canada.ca/en/alert-recall/pfizer-recalls-accuretic-blood-pressure-tablets-due-nitrosamine-impurity
https://www.pharmtech.com/view/usp-s-nitrosamine-impurity-standard-is-now-official
https://www.usp.org/news/usp-standard-for-nitrosamine-impurities-becomes-official
https://www.raps.org/news-and-articles/news-articles/2021/10/fda-suggests-alternative-approaches-for-nitrosamin
https://pharmaceutical-journal.com/article/news/pfizer-recalls-all-stock-of-smoking-cessation-medicine-over-nitrosamine-contamination
https://www.pharmtech.com/view/nitrosamine-risk-assessment-date-extended
https://pink.pharmaintelligence.informa.com/PS142872/USP-Proposes-Analytical-Methods-For-Drug-Makers-To-Detect-Nitrosamine-Impurities
https://www.fda.gov/drugs/news-events-human-drugs/rigorous-detection-nitrosamine-contaminants-metformin-products-balancing-product-safety-and-product
https://www.newswire.ca/news-releases/information-update-ranitidine-products-recalled-because-of-a-nitrosamine-impurity-843285913.html
https://www.raps.org/news-and-articles/news-articles/2020/8/fda-addresses-nitrosamines-in-tb-drugs
https://www.fda.gov/drugs/drug-safety-and-availability/fda-works-mitigate-shortages-rifampin-and-rifapentine-after-manufacturers-find-nitrosamine#:~:text=To%20mitigate%20or%20avoid%20shortages,CPNP)%20above%20the%20acceptable%20intake
https://www.pharmaexcipients.com/news/nitrosamines-risk-assessments-for-basfs-pharmaceutical-excipients/
https://pink.pharmaintelligence.informa.com/PS142538/Biologicals-Join-List-Of-EU-Medicines-Requiring-Nitrosamine-Evaluation
https://www.prnewswire.com/news-releases/fda-alerts-patients-and-health-care-professionals-to-nitrosamine-impurity-findings-in-certain-metformin-extended-release-products-301067454.html
https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure
https://www.ema.europa.eu/en/news/ema-advises-companies-steps-take-avoid-nitrosamines-human-medicines
https://www.ema.europa.eu/en/news/ema-provide-guidance-avoiding-nitrosamines-human-medicines
https://www.nbcnews.com/health/heart-health/fda-expands-blood-pressure-drug-recall-fifth-time-year-n998911
https://www.raps.org/news-and-articles/news-articles/2019/4/ema-urges-pioglitazone-manufacturers-to-check-for
https://www.biospace.com/article/releases/fda-provides-update-on-its-ongoing-investigation-into-arb-drug-products-reports-on-finding-of-a-new-nitrosamine-impurity-in-certain-lots-of-losartan-and-product-recall/
Market Place
Share 
